JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 22 No. 9 793-795
© 1981 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szpunar, W. E.
Right arrow Articles by Bednarz, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szpunar, W. E.
Right arrow Articles by Bednarz, M. N.

Clinical Evaluation of a Thyroxine-Binding Globulin Assay in Calculating a Free-Thyroxine Index

Walter E. Szpunar, Sheldon S. Stoffer and Miroslava N. Bednarz

Associated Endocrinologists, Southfield, Michigan

Correspondence: For reprints contact: Walter E. Szpunar, PhD, Associated Endocrinologists, 4400 Town Center, Suite 275, Southfield, MI 48075.

ABSTRACT

A free-thyroxine index (FTI) using the thyroxine-binding globulin (TBG) assay of Corning Medical (FTI-TBG) was compared with a FTI using a tri-iodothyronine (T3) uptake (FTI-T3U) in 173 patients. Markedly elevated FTI-TBG values were obtained in clinically euthyroid patients with a relatively low T3 uptake and an elevated thyroxine level. In contrast, the FTI-T3U values for these same patients agreed with the clinical evaluation.Under these circumstances, the T3 uptake is clearly superior to the TBG assay in calculating a free-thyroxine index.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1981 by the Society of Nuclear Medicine.